Search

Abstract: Carbon dioxide was photo-catalytically reduced to produce formic acid in an aqueous solution using visible light irradiation. Titania and zinc-phthalocyanine (ZnPc)-loaded titania were synthesized by a sol–gel method and in situ chemical synthesis technique. The photo-catalytic reactions were conducted in a Pyrex reactor with a visible light irradiating. XRD and DRS revealed that ZnPc was on the TiO2 surface. The optimum technique was in situ chemical synthesis and the optimum amount of ZnPc loading was 1.0wt.% for the highest dispersion among catalysts. The formic acid yield of 1.0wt.% in situ ZnPc/TiO2 was 978.6μmol/g catalyst following 10h of visible light illumination and the conversion was 0.37%. The yield was higher than those of sol–gel TiO2 and ZnPc/BH-1, whose yields were 321.0 and 756.2μmol/g catalyst, respectively. Experimental results indicated that the formic acid yield was significantly increased by loading ZnPc. ZnPc has a higher selectivity than metal catalysts for the reduction of CO2. The photo-catalytic efficiency of ZnPc/TiO2 was markedly increased because of the lowering re-combination probability for hole–electron pairs. [Copyright &y& Elsevier]

N and F co-doped La-TiO₂ (La-TONF) samples were prepared through the solvothermal method by using HMT and NaF as precursors. The obtained samples were characterized by UV-Vis DRS, XRD, XPS and PL measurements for light-harvesting properties, crystal phase and optical characteristics, respectively. Interestingly, the TONF sample had a different fluorescence emission intensity than the TON or TOF samples, thus suggesting a clear synergistic effect of N and F co-doping. The optimal doping amount of La was 2 wt.%, and the absorption edge was red-shifted from 453 nm to 464 nm for La-TiO₂ and La-TONF. The photocatalytic activity was evaluated by degradation of MO and oxidation of TMB under visible light irradiation. La-TONF exhibited excellent photocatalytic activity and a degradation rate of 92.4%, 4.4 times that of undoped TiO₂ (20.8%). The photocatalytic degradation activity remained above 85.8%, even after five runs. In addition, the MO photodegradation catalyzed by La-TONF followed first order kinetics. According these results, a possible synergistic effect mechanism for the enhanced photocatalytic performance is proposed.

Fly ash is a solid waste discharged from thermal power plant. Specific surface area of floating fly ash cenospheres (FACs) would increase after it was modified. The photocatalytic composite of TiO2/FACs was successfully synthesized by sol-gel method using the carrier of modified FACs and tetrabutyl titanate as starting materials. The different influence factors on the photocatalytic performance of TiO2/FACs composites were characterized through SEM, EDS, XRD, UV-vis DRS and BET surface measurements. The UV-vis DRS spectra revealed that the absorption edge of TiO2 is 387 nm while that of TiO2/FACs photocatalysts red-shifts to 500 nm. Photocatalytic activity of TiO2/FACs was evaluated by the photocatalytic depigmentation of methyl orange solution (MO, 20 mg L-1, pH = 6.3) under visible light irradiation. It was found that the specific surface area, surface roughness and activity of FACs were increased by NaOH solution activation. The degradation rate of MO reaches 52% in 180 min under the visible light illumination. But too much FACs could decrease its photocatalytic activity and degradation rate. And the recovery test indicated that TiO2/FACs photocatalyst was rather stable, easy to recover from the treated wastewater.

Metal ions (Cr, Ni, Co) doped titania (M-TiO2) coupled with the long after glow phosphor MgAl2O4:(Pr3+, Dy3+) particles were synthesized by the sol-gel method, with the best mass ratio of MgAl2O4:(Pr3+, Dy3+) to M-TiO2 as 4:6. MgAl2O4:(Pr3+, Dy3+)/M-TiO2 had the persistent methyl orange (MO) photocatalytic degradation ability and the photocatalytic degradation went on reacting more than 90 min in dark after turning off the light. MgAl2O4:(Pr3+, Dy3+) emitted the light as a light source in dark which was absorbed by M-TiO2. The differences of MgAl2O4:(Pr3+, Dy3+)/Cr-TiO2, MgAl2O4:(Pr3+, Dy3+)/Ni-TiO2 and MgAl2O4:(Pr3+, Dy3+)/Co-TiO2 might be attributed to the difference in the metal ions doping. The composite MgAl2O4:(Pr3+, Dy3+)/Cr-TiO2 revealed the highest ability of persistent photocatalytic degradation methyl orange. Different metal ions doping made the TiO2 with different band gap.

Background: The role of the antioxidant N-acetylcysteine (NAC) in the treatment of chronic obstructive pulmonary disease (COPD) has not been clarified as yet. In early studies, we found that the proportion of smokers with COPD having extremely slow/slow microsomal epoxide hydrolase (EPHX1) enzyme activity is significantly higher than that in healthy smokers. The purpose of this study was to evaluate whether different EPHX1 enzyme activity is related to differential therapeutic effects of treatment with NAC in COPD., Methods: A total of 219 patients with COPD were randomly allocated to an extremely slow/slow EPHX1 enzyme activity group (n=157) or a fast/normal EPHX1 enzyme activity group (n=62) according to their EPHX1 enzyme activity. Both groups were treated with NAC 600 mg twice daily for one year. The main study parameters, including forced expiratory volume in one second (FEV1), St George's Respiratory Questionnaire (SGRQ), and yearly exacerbation rate, were measured at baseline and at 6-month intervals for one year., Results: Both FEV1 and SGRQ symptom scores were improved after treatment with NAC in the slow activity group when compared with the fast activity group. Further, changes in FEV1 and SGRQ symptom score in patients with mild-to-moderate COPD were more significant than those in patients with severe-to-very severe COPD. The yearly exacerbation rates were reduced in both groups, but the reduction in the slow activity group was significantly lower than in the fast activity group., Conclusion: NAC treatment in COPD patients with extremely slow/slow EPHX1 enzyme activity improves FEV1 and the SGRQ symptom score, especially in those with mild-to-moderate COPD, and polymorphism in the EPHX1 gene may have a significant role in differential responses to treatment with NAC in patients with COPD.